MED12 and Uterine leiomyoma: An other series of eight cases60 found through immunohistochemistry that all uterine and extra-uterine tumors were positive for HMGA2 (over-expression) and MED12 (either mutation or low expression), both in uterine and extra-uterine leiomyomas.